Olfactory mucosa steroid injection in treatment of post-COVID-19 olfactory dysfunction: a randomized control trial
Abstract Background Olfactory dysfunction can be a troublesome condition affecting the quality of life of the patient. Post-viral olfactory dysfunction is the most common cause attributing to up to 40% of anosmia. COVID-19 infection commonly causes anosmia in 30–66% of patients. The long-term effect...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-08-01
|
| Series: | The Egyptian Journal of Otolaryngology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43163-023-00478-0 |